Literature DB >> 31527834

PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity.

W Nicholas Haining1,2, Arlene H Sharpe3,4,5, Martin W LaFleur6,7,8,9, Thao H Nguyen6,8, Matthew A Coxe6,8, Brian C Miller6,7,8,10,11, Kathleen B Yates7,10, Jacob E Gillis6,8, Debattama R Sen7,9,10, Emily F Gaudiano6,8, Rose Al Abosy7, Gordon J Freeman11.   

Abstract

CD8+ T cell exhaustion is a state of dysfunction acquired in chronic viral infection and cancer, characterized by the formation of Slamf6+ progenitor exhausted and Tim-3+ terminally exhausted subpopulations through unknown mechanisms. Here we establish the phosphatase PTPN2 as a new regulator of the differentiation of the terminally exhausted subpopulation that functions by attenuating type 1 interferon signaling. Deletion of Ptpn2 in CD8+ T cells increased the generation, proliferative capacity and cytotoxicity of Tim-3+ cells without altering Slamf6+ numbers during lymphocytic choriomeningitis virus clone 13 infection. Likewise, Ptpn2 deletion in CD8+ T cells enhanced Tim-3+ anti-tumor responses and improved tumor control. Deletion of Ptpn2 throughout the immune system resulted in MC38 tumor clearance and improved programmed cell death-1 checkpoint blockade responses to B16 tumors. Our results indicate that increasing the number of cytotoxic Tim-3+CD8+ T cells can promote effective anti-tumor immunity and implicate PTPN2 in immune cells as an attractive cancer immunotherapy target.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31527834      PMCID: PMC6754306          DOI: 10.1038/s41590-019-0480-4

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  54 in total

Review 1.  Navigating CAR-T cells through the solid-tumour microenvironment.

Authors:  Andrew J Hou; Laurence C Chen; Yvonne Y Chen
Journal:  Nat Rev Drug Discov       Date:  2021-05-10       Impact factor: 84.694

Review 2.  CD8+ T cell states in human cancer: insights from single-cell analysis.

Authors:  Anne M van der Leun; Daniela S Thommen; Ton N Schumacher
Journal:  Nat Rev Cancer       Date:  2020-02-05       Impact factor: 60.716

3.  CD4+ T cell exhaustion leads to adoptive transfer therapy failure which can be prevented by immune checkpoint blockade.

Authors:  Jinfei Fu; Anze Yu; Xiang Xiao; Juyu Tang; Xiongbing Zu; Wenhao Chen; Bin He
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

Review 5.  Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms.

Authors:  Iñaki Etxeberria; Irene Olivera; Elixabet Bolaños; Asunta Cirella; Álvaro Teijeira; Pedro Berraondo; Ignacio Melero
Journal:  Cell Mol Immunol       Date:  2020-05-20       Impact factor: 11.530

6.  microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.

Authors:  Michal J Besser; Gal Markel; Gilli Galore-Haskel; Eyal Greenberg; Inbal Yahav; Ettai Markovits; Rona Ortenberg; Ronnie Shapira-Fromer; Orit Itzhaki; Jacob Schachter
Journal:  Cancer Immunol Immunother       Date:  2020-11-17       Impact factor: 6.968

Review 7.  T cell factor 1: A master regulator of the T cell response in disease.

Authors:  Giulia Escobar; Davide Mangani; Ana C Anderson
Journal:  Sci Immunol       Date:  2020-11-06

8.  Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development.

Authors:  Egle Katkeviciute; Larissa Hering; Ana Montalban-Arques; Philipp Busenhart; Marlene Schwarzfischer; Roberto Manzini; Javier Conde; Kirstin Atrott; Silvia Lang; Gerhard Rogler; Elisabeth Naschberger; Vera S Schellerer; Michael Stürzl; Andreas Rickenbacher; Matthias Turina; Achim Weber; Sebastian Leibl; Gabriel E Leventhal; Mitchell Levesque; Onur Boyman; Michael Scharl; Marianne R Spalinger
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  TAFs contributes the function of PTPN2 in colorectal carcinogenesis through activating JAK/STAT signaling pathway.

Authors:  Wei Zhao; Lei Hao; Lizhou Jia; Jinsong Wang; Bin Wang; Yanqiang Huang; Youcai Zhao
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 10.  Cellular networks controlling T cell persistence in adoptive cell therapy.

Authors:  Jack D Chan; Junyun Lai; Clare Y Slaney; Axel Kallies; Paul A Beavis; Phillip K Darcy
Journal:  Nat Rev Immunol       Date:  2021-04-20       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.